SLC20A1 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL267024	1.00	1/20
SCHEMBL267025	1.00	1/20
SCHEMBL7126685	0.83	1/20
SCHEMBL267842	0.80	1/20
SCHEMBL267843	0.80	1/20
SCHEMBL267856	0.80	1/20
SCHEMBL267857	0.80	1/20
SCHEMBL267924	0.79	1/20
SCHEMBL267925	0.79	1/20
SCHEMBL268319	0.78	1/20
SCHEMBL268320	0.78	1/20
SCHEMBL274252	0.78	1/20
SCHEMBL266512	0.76	1/20
SCHEMBL266513	0.76	1/20
SCHEMBL267960	0.76	1/20
SCHEMBL267961	0.76	1/20
SCHEMBL267826	0.75	1/20
SCHEMBL267827	0.75	1/20
SCHEMBL274075	0.75	1/20
SCHEMBL7120286	0.74	1/20

Clinical trials — most relevant to SLC20A1 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Effect of Age on the Renal Clearance of Adefovir	PHASE4	WITHDRAWN
Study of the Anti-FGF23 Antibody, Burosumab, in Adults With XLH	PHASE3	COMPLETED
Applying Proton Pump Inhibitor to Prevent and Treat Acute Fluctuating Hearing Loss in Patients With SLC26A4 Mutation	PHASE2/PHASE3	UNKNOWN
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease	PHASE2	COMPLETED
Healthy Combine Study	PHASE1	COMPLETED
Statin Therapy to Improve Medication Adherence	PHASE1	COMPLETED
Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters	EARLY_PHASE1	COMPLETED
Natural History Study of SLC25A46 Mutation-related Mitochondriopathy	nan	COMPLETED
Cardiovascular Effects of Empagliflozine	nan	UNKNOWN
Oxalate and Citrate in Humans - Response to Citrate	nan	RECRUITING
The Effectiveness and Safety of Calcium Carbonate in Chronic Kidney Disease With Normophosphatemia	nan	COMPLETED
Prevalence and Risk Factors of Nephrocalcinosis in Children at Sohag University Hospital	nan	UNKNOWN
Sodium Transport: Genetics and Hypertension	nan	COMPLETED
Calcitonin for Treating X-linked Hypophosphatemia	nan	COMPLETED
POTASSIUM-RICH SALT SUBSTITUTES IN KIDNEY TRANSPLANT RECIPIENTS	nan	NOT_YET_RECRUITING
Oxalate and Citrate	nan	RECRUITING
Genetic Variations That Increase the Risk for Calcium Kidney Stones: a Family-based Study	nan	COMPLETED
Lithium Countertransport and Blood Pressure In CARDIA and TOMHS	nan	COMPLETED
Blood Pressure Control in Juveniles - Longitudinal Study	nan	COMPLETED
Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts	nan	COMPLETED
Epidemiology of Gout in French Polynesia	nan	COMPLETED
Studying Phosphorus Metabolism	nan	COMPLETED
Institution of an Italian Multicenter Database of Patients Affected by Diseases of Phosphate Metabolism	nan	NOT_YET_RECRUITING
Biological Collection of Kidney Cells	nan	UNKNOWN
Bile Acid Effects in Fetal Arrhythmia Study	nan	UNKNOWN
Cardiorenal Risk Stratification Pilot Study	nan	UNKNOWN
Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management	nan	UNKNOWN
Impact of Polymorphisms of OAT1, OAT3, and OCT2 on Transportation of Potential Nephrotoxic Drugs	nan	COMPLETED
Kidney-protective Intervention With Salt Substitute After Kidney Tumor Surgery	nan	RECRUITING
Genetic and Biohumoral Factors Involved in Menière's Disease and Their Correlation With Phenotypes	nan	RECRUITING

Related proteins — ESM-2 sequence neighbours (a SLC20A1 binder may also engage these)

Protein	Name	Similarity
O97596	—	1.000	O97596 →
Q5R9L5	—	1.000	Q5R9L5 →
Q28E01	—	1.000	Q28E01 →
Q9JJP0	—	1.000	Q9JJP0 →
Q61609	—	1.000	Q61609 →
Q6PB26	—	1.000	Q6PB26 →
Q5BL44	—	1.000	Q5BL44 →
SLC20A2	Sodium-dependent phosphate transporter 2	0.999	landscape →
Q6PFM1	—	0.998	Q6PFM1 →
Q5XHF9	—	0.998	Q5XHF9 →
Q95L97	—	0.996	Q95L97 →
Q68F35	—	0.996	Q68F35 →
Q80UP8	—	0.995	Q80UP8 →
A1A4I1	—	0.995	A1A4I1 →
Q9ES44	—	0.995	Q9ES44 →
Q6NV12	—	0.994	Q6NV12 →
Q63488	—	0.993	Q63488 →
Q27960	—	0.983	Q27960 →
Q9JIS8	—	0.981	Q9JIS8 →
Q5REV9	—	0.980	Q5REV9 →
Q924N4	—	0.980	Q924N4 →
P15710	—	0.979	P15710 →
Q9DBP0	—	0.979	Q9DBP0 →
Q9UHW9	—	0.977	Q9UHW9 →
Q5DTL9	—	0.977	Q5DTL9 →
Q923J4	—	0.977	Q923J4 →
O88343	—	0.977	O88343 →
SLC12A5	Solute carrier family 12 member 5	0.977	landscape →
Q9JJ09	—	0.977	Q9JJ09 →
Q5RK27	—	0.977	Q5RK27 →